Nationwide effect of high procedure volume in lung cancer surgery on in-house mortality in Germany

Lung cancer is the number one cause of cancer deaths worldwide and treatment is expensive [1]. First-line therapy in early-stage lung cancer is surgical resection if appropriate from a technical and oncological perspective [2]. High variability in operative mortality and morbidity have been reported, and these characteristics are an indicator of poor-quality surgical care [3]. Treatment at high-volume hospitals is related to improved perioperative and postoperative outcomes, especially from United States ’ data [4–7].

Source: Lung Cancer - August 30, 2020 Category: Cancer & Oncology Authors: Philip Baum, Johannes Diers, Johannes Haag, Laura Klotz, Florian Eichhorn, Martin Eichhorn, Armin Wiegering, Hauke Winter Source Type: research